159 related articles for article (PubMed ID: 28629825)
1. ICT1 predicts a poor survival and correlated with cell proliferation in diffuse large B-cell lymphoma.
Xie W; Wu M; Fu T; Li X; Wang Z; Hu Y; Zhu L; Zhang G
Gene; 2017 Sep; 627():255-262. PubMed ID: 28629825
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of immature colon carcinoma transcript 1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.
Li GY; Liu JZ; Zhang L; Liu GZ; Li SJ; Xiao TW; Wang JX; Wang LX; Hou M
Oncol Rep; 2018 Mar; 39(3):1269-1275. PubMed ID: 29328466
[TBL] [Abstract][Full Text] [Related]
3. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
4. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
Chang W; Yu Z; Tian M; Lin X
Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
[TBL] [Abstract][Full Text] [Related]
5. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
Peng X; Yan B; Shen Y
Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
[TBL] [Abstract][Full Text] [Related]
6. Immature colon carcinoma transcript-1 promotes proliferation of gastric cancer cells.
Wang Z; Jin G; Wu Q; Wang R; Li Y
Acta Biochim Biophys Sin (Shanghai); 2017 Nov; 49(11):979-988. PubMed ID: 29036264
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.
Wang Y; He J; Zhang S; Yang Q; Wang B; Liu Z; Wu X
Technol Cancer Res Treat; 2017 Oct; 16(5):559-569. PubMed ID: 27413166
[TBL] [Abstract][Full Text] [Related]
8. ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.
Wang C; Liang C; Feng W; Xia X; Chen F; Qiao E; Zhang X; Chen D; Ling Z; Yang H
Int J Mol Med; 2017 Apr; 39(4):1037-1045. PubMed ID: 28290601
[TBL] [Abstract][Full Text] [Related]
9. ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
Wu J; He Z; Zhu Y; Jiang C; Deng Y; Wei B
Curr Cancer Drug Targets; 2021; 21(1):80-89. PubMed ID: 32933462
[TBL] [Abstract][Full Text] [Related]
10. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
[TBL] [Abstract][Full Text] [Related]
11. Immature Colon Carcinoma Transcript 1 Is Essential for Prostate Cancer Cell Viability and Proliferation.
Wang Z; Xu D; Gao Y; Liu Y; Ren J; Yao Y; Yin L; Chen J; Gan S; Cui X
Cancer Biother Radiopharm; 2015 Sep; 30(7):278-84. PubMed ID: 26186090
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.
Zhu FQ; Zeng L; Tang N; Tang YP; Zhou BP; Li FF; Wu WG; Zeng XB; Peng SS
Oncol Res; 2016 Oct; 24(6):415-427. PubMed ID: 28281962
[TBL] [Abstract][Full Text] [Related]
13. Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway.
Cui Y; Wen Y; Lv C; Zhao D; Yang Y; Qiu H; Wang C
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894142
[TBL] [Abstract][Full Text] [Related]
14. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.
Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X
Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819
[TBL] [Abstract][Full Text] [Related]
15. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
16. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
17. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
Peng W; Feng J
Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
